Keywords
deep sternal wound infections - clopidogrel - anticoagulation - immunosuppression
- body mass index
Introduction
Deep sternal wound infections (DSWIs) are a serious complication following sternotomy
for cardiothoracic surgery. “Conventional” treatment provides debridement and secondary
closure or closed catheter irrigation.[1] Risk factors for the development of DSWIs after median sternotomy include diabetes,
obesity, chronic obstructive pulmonary disease, osteoporosis, tobacco use, reoperation,
prolonged intensive care unit stays, and use of assistive devices.[2] The Pairolero classification of infected median sternotomies divides wounds into
three types based on duration and clinical findings.[3]
[4] Type I infections occur within the first week after sternotomy and typically have
serosanguineous drainage but no cellulitis, osteomyelitis, or costochondritis and
type II infections, which occur during the second to fourth weeks after sternotomy
and usually involve purulent drainage, cellulitis, and mediastinal suppuration. Costochondritis
is rare, but osteomyelitis is frequent. Type III infections occur months to years
after sternotomy and typically involve chronic draining sinus tracts and localized
cellulitis. Although mediastinitis is rare, osteomyelitis, costochondritis, and/or
retained foreign bodies are often present.
Treatment ranges from antibiotics and a single-stage operation, debridement of all
necrotic tissues with removal of all foreign materials and exposed cartilage in subtotal
sternotomy and muscle flap coverage, as also noted in the current S3 guidelines on
the management of mediastinitis after cardiac surgery.[4]
[5]
[6]
[7] After radical infection repair by subtotal sternotomy and defect coverage by a muscle
flap, some patients develop a new wound healing disorder, which often leads to reoperation
and prolonged hospitalization.[8]
[9] Treatment of these patients is time-consuming and recurrence of infection cannot
be excluded in any case.
The aim of this study was to define determinants of length of hospital stay and recurrence
of infection after complete healing of patients with DSWI to identify at admission
patients who are likely to have a length of stay (LOS) above the mean LOS or recurrence
of infection (ROI).
Patients and Methods
The Department of Plastic Surgery of the HELIOS Klinik Krefeld is specialized in the
treatment of patients with DSWI, and patients come from a major part of western Germany.
From 2016 to 2020, 303 patients were treated. All patients received detailed documentation
of their medical history, a clinical examination, determination of blood values, and
bacterial infection. Initial treatment started with extensive debridement and necrosectomy
([Table 1]). In all patients, the sternum was subtotally removed. Repetitive negative pressure
therapy was given until the tissue was prepared for transplantation of a pectoral
musculocutaneous flap. In total, 155 patients were female and 148 were male (mean
age was 68 years). Six patients died in the hospital during treatment due to myocardial
infarction and sepsis. The median inpatient LOS was 43 days.
Table 1
Patients' characteristic by admission to hospital separated by the endpoint
|
I02B (n = 246)
|
I02C/I02D (n = 57)
|
ROI (n = 49)
|
|
Age (mean ± SD)
|
67.7 ± 9.4
|
69.3 ± 9.4
|
66.5 ± 9.4
|
|
Females, n (%)
|
123 (50.0)
|
32 (56.1)
|
31 (63.3)
|
|
Diabetes mellitus, n (%)
|
134 (54.5)
|
30 (52.6)
|
27 (55.1)
|
|
Hypertension, n (%)
|
236 (95.9)
|
55 (96.5)
|
49 (100)
|
|
Renal insufficiency, n (%)
|
120 (48.8)
|
32 (56.1)
|
30 61.1)
|
|
Obesity, n (%)
|
185 (75.2)
|
39 (68.4)
|
36 (73.5)
|
|
Smoking, n (%)
|
92 (37.4)
|
30 (52.6)
|
22 (44.9)
|
|
Prior resternotomy, n (%)
|
26 (10.6)
|
3 (5.3)
|
5 (10.2)
|
|
Anemia, n (%)
|
228 (92.7)
|
53 (93.0)
|
47 (95.9)
|
|
CRP, n (%)
|
245 (99.6)
|
57 (100)
|
49 (100)
|
|
Hypoalbuminemia, n (%)
|
165 (67.1)
|
37 (64.9)
|
33 (67.3)
|
|
Immunosuppression, n (%)
|
15 (6.1)
|
3 (5.3)
|
6 (12.2)
|
|
Prophylactic anticoagulation, n (%)
|
144 (58.5)
|
32 (56.1)
|
28 (57.1)
|
|
Prophylactic anticoagulation and clopidogrel, n (%)
|
50 (20.3)
|
6 (10.5)
|
8 (16.3)
|
|
Therapeutic anticoagulation, n (%)
|
102 (41.5)
|
25 (43.9)
|
21 (42.9)
|
|
Therapeutic anticoagulation and clopidogrel, n (%)
|
18 (7.3)
|
0
|
3 (6.1)
|
Abbreviations: CRP, C-reactive protein; ROI, recurrence of Infection; SD, standard
deviation.
Determinants of Length of Stay Longer than Mean Length of Stay
Mean LOS was 43 days and ranged from 16 to 168 days. We were interested in determining
that if there are any determinants at the time of hospital admission that are associated
with an LOS longer than the mean LOS calculated by the German diagnosis-related group
(DRG) system.
Depending on the intensity of treatment and the number of surgical procedure, all
patients were categorized into three DRGs with different LOS.
DRG IO2B (n = 246): Patients in this group had four or more surgical procedures and mean LOS
in the DRG-system was calculated as 39.5 days (lower borderline 12 and upper borderline
58 days).
DRG I02C and I02D (n = 57): Patients in this group had less than four surgical procedures. In the I02C
group, mean LOS was calculated as 31.6 days (10–50 days). LOS days in the I02D group
were 27.6 days (8–46 days). The grouping was based on the DRG system from the year
2020.
Determinants of Recurrence of Infection after Healing
ROI requiring revision during the same hospital stay was defined as “necessity to
perform a new surgical debridement, abscess drainage or transplantation days after
primary healing of the pectoral muscle flap.” It occurred in 49 patients (31 females
and 18 males). The median LOS was 58 days in this group.
Included Variables
Variables included in the analyses are listed in [Table 1]. Body mass index (BMI) was classified according to the World Health Organization
classification into normal weight up to a BMI of 24.9 and overweight above 25. Smoking
was assigned as a risk factor for those who consumed nicotine at the time of their
disease.
Arterial hypertension was considered a risk factor when there was the use of at least
one antihypertensive drug.
In addition, the presence of chronic renal insufficiency was included as a risk factor.
The severity of renal failure was not considered in detail. At a glomerular filtration
rate of 89 or less on the day of hospitalization, the kidney was considered to have
reduced function
Further, the presence of hypalbuminemia (albumin less than 3.5 g/L), anemia (hemoglobin
[Hb] value less than 14 g/dL in men and less than 12.3 g/dL in women), elevated C-reactive
protein (CRP; value greater than 0.5 mg/dL), and diabetes mellitus (taking oral antidiabetics
or insulin or Hba1c greater than 6.5% on hospital admission) at inpatient admission
was investigated.
The use of angiotensin-converting enzyme inhibitors, calcium antagonists, and immunosuppressant
drugs was also studied. The medication at the inpatient admission of the patient was
examined.
In addition, perioperative anticoagulation was examined in more detail. A total of
four groups were formed for this purpose: one group in which patients received only
prophylactic anticoagulation with heparin or enoxaparin, one group in which patients
additionally received clopidogrel, one group in which patients were therapeutically
anticoagulated with heparin or enoxaparin, and one in which patients received clopidogrel
and therapeutic anticoagulation.
Other potential risk factor included the performance of resternotomy during the initial
cardiac surgery procedure.
Statistical Methods
The aim of our statistical analysis was to determine a logistic regression model for
the dependent variables LOS above mean LOS and ROI after complete healing. Furthermore,
we wanted to quantify the fit of our models and the ability to discriminate between
the patients.
In the case of the dependent variable ROI after complete healing, we split the entire
sample of 303 patients randomly into two subgroups of 152 patients (subgroup 1) and
151 patients (subgroup 2).
The logistic regression model was then estimated for subgroup 1. For this model identification,
we applied three different types of variable selection, namely forward, backward,
and stepwise selection. The model with the lowest value of the Akaike information
criterion was chosen.[10] For the dependent variable ROI after complete healing and subgroup 1, the explanatory
variables BMI and immunosuppression were identified as the most important determinants.
The fit of our calculated model was then analyzed based on subgroup 2. For this purpose,
we determined the average over the predicted probabilities of the event ROI after
complete healing (for every patient) in the decentiles of subgroup 2. We also calculated
the relative inference for this event for the same decentiles, stated as observed
values. The observed and the predicted values were plotted, to check if they differ
greatly from each other. The goodness of this model fit was quantified by applying
the Hosmer–Lemeshow test.
The variables BMI and immunosuppression were then used to calculate a logistic regression
model for the entire patient population, so for all 303 patients.
The identically procedure was used for analyzing the determinants of the dependent
variable I02B, with a sample size of 246 patients. The identified explanatory variables are gender,
therapeutical anticoagulation and clopidogrel, clopidogrel, and renal insufficiency
defined by glomerular filtration rate. The identified explanatory variables which
we used for the logistic regression for I02B were also applied to determine the logistic regression models for I02C and I02D. The samples of I02C and I02D were not randomly split into two subgroups, since the sample sizes of I02C and I02D consist only of 57 patients, which is too small for sample splitting.
All surveys were performed with the approval of the relevant ethics committee, in
accordance with national law and in accordance with the declaration of Helsinki of
1975 (in the current, revised version). All participating patients or their legal
guardians gave consent before inclusion into the trial. All statistical procedures
were calculated via SAS 9.4.
Results
[Table 1] shows the patients' characteristics separated for the different groups (endpoint:
I02B, endpoint: I02C/I02D, endpoint: ROI after complete healing).
Among patients in the DRG IO2B (n = 246) treated with four or more surgical procedures, mean LOS defined by the DRG
system is 39.5 days. In total, 132 patients had a longer LOS than mean. In the multivariate
analysis, the variable clopidogrel and therapeutic anticoagulation, which was present in 7.3% of patients, was the most important determinant for a LOS
longer than mean with an odds ratio of 3.56 (95% CI = 1.03/12.26) in the overall group
and of 5.83 (95% CI = 0.83/40.80; [Table 2]) in the subgroup 1. Female gender and renal insufficiency also prolonged LOS. The
results of the Hosmer–Lemeshow test are shown in [Table 3]. ROC curve ([Fig. 1]) and model fit ([Fig. 2]) showed the discriminatory power of the model as well as the goodness of fit to
the data. The area under the curve (AUC) was 0.62, and the p-value of the Hosmer–Lemeshow test was 0.83 so that the null hypothesis “observed
and predicted values are equal” could not be rejected.
Fig. 1 ROC curve predicting events based on our model for the LOS longer than mean LOS (upper)
and ROI after healing (lower).
Fig. 2 Model fit predicting events based on our model for the LOS longer than mean LOS (upper)
and ROI after healing (lower).
Table 2
Odds ratio (OR) of the determinants of an LOS longer than mean in patients grouped
in DRG I02B in subgroup 1
|
Effect
|
OR
|
95% Wald confidence limits
|
|
Gender, female vs. male
|
2.17
|
1.0
|
4.74
|
|
Clopidogrel +_therapeutic anticoagulation, yes vs. no
|
5.83
|
0.83
|
40.80
|
|
Clopidogrel, yes vs. no
|
0.25
|
0.06
|
0.99
|
|
Renal insufficiency, yes vs. no
|
1.04
|
0.69
|
1.56
|
Abbreviation: LOS, length of stay.
Table 3
Hosmer–Lemeshow test including determinants of [Table 5] in subgroup 2
|
Decentile
|
Sum
|
LOS longer than mean
|
LOS not longer than mean
|
|
Observed
|
Predicted
|
Observed
|
Predicted
|
|
1
|
14
|
4
|
5.17
|
10
|
8.83
|
|
2
|
15
|
9
|
6.91
|
6
|
8.09
|
|
3
|
15
|
6
|
7.07
|
9
|
7.93
|
|
4
|
14
|
7
|
6.77
|
7
|
7.23
|
|
5
|
9
|
6
|
4.81
|
3
|
4.19
|
|
6
|
23
|
13
|
13.64
|
10
|
9.36
|
|
7
|
23
|
13
|
13.92
|
10
|
9.08
|
|
8
|
10
|
7
|
6.70
|
3
|
3.30
|
Abbreviation: LOS, length of hospital stay.
Applying this analysis to the patient group in DRG I02C and I02D (n = 57), none of this parameter was predictive. Applying it to the patients with the
endpoint ROI after complete healing (n = 49), the variables therapeutic anticoagulation, renal insufficiency, and gender
had a much lower impact.
Doing a new separate analysis in these patients, ROI after complete healing showed
that the variable immunosuppression, which was present in 12.2% of the patients, is
the most important determinant with an odds ratio of 4.67 (95% CI: 1.01/21.52) in
the subgroup and an odds ratio of 3.03 (95% CI: 1.07/8.59) in the overall group. Obesity
was relevant too, but with a much lower impact. Odds ratio was 1.10 (95% CI: 1.03/1.17)
in the subgroup. The result of the Hosmer–Lemeshow test is shown in [Table 4]. The p-value of the Hosmer–Lemeshow test was 0.34 so that the null hypothesis “observed
and predicted values are equal” could not be rejected. Although the p-value was not as large as for I02B, it indicated that the fit is not too bad. The
ROC curve had an AUC of 0.69.
Table 4
Hosmer–Lemeshow test for ROI in subgroup 2
|
Decentile
|
Sum
|
Surgical revision because of ROI
|
No surgical revision because of ROI
|
|
Observed
|
Predicted
|
Observed
|
Predicted
|
|
1
|
15
|
1
|
1.98
|
14
|
13.02
|
|
2
|
15
|
5
|
2.32
|
10
|
12.68
|
|
3
|
16
|
1
|
2.68
|
15
|
13.32
|
|
4
|
17
|
3
|
3.03
|
14
|
13.97
|
|
5
|
15
|
3
|
2.78
|
12
|
12.22
|
|
6
|
15
|
4
|
2.89
|
11
|
12.11
|
|
7
|
15
|
1
|
3.00
|
14
|
12.00
|
|
8
|
15
|
4
|
3.13
|
11
|
11.87
|
|
9
|
15
|
2
|
3.27
|
13
|
11.73
|
|
10
|
13
|
5
|
3.92
|
8
|
9.08
|
|
Hosmer and Lemeshow goodness-of-fit test
|
|
Chi-quadrat
|
DF
|
Pr > ChiSq
|
|
9.07
|
8
|
0.34
|
Abbreviation: ROI, recurrence of infection.
Table 5
Included variables and their definitions
|
Step
|
Variable
|
Definition
|
|
1
|
Diabetes mellitus
|
Oral antidiabetics or insulin or Hba1c greater than 6.5% on hospital admission
|
|
2
|
Hypertension
|
Use of at least one antihypertensive drug at inpatient admission
|
|
3
|
Renal insufficiency
|
Glomerular filtration rate of 89 or less on the day of hospitalization
|
|
4
|
Obesity
|
Body mass index greater than/ equal to 25 on the day of hospitalization
|
|
5
|
Smoking
|
Nicotine consumption at the time of the disease
|
|
6
|
Resternotomie
|
As part of the initial cardiac surgery procedure
|
|
7
|
Anemia
|
Hb value less than 14 g/dL in men and less than 12.3 g/dL in women on the day of hospitalization
|
|
8
|
CRP
|
CRP value greater than 0.5 mg/dL on the day of hospitalization
|
|
9
|
Hypoalbuminemia
|
Albumin less than 3.5 g/L on the day of hospitalization
|
|
10
|
Immunosuppression
|
Yes or no at inpatient admission
|
|
11
|
Prophylactic anticoagulation
|
Prophylactic anticoagulation with heparin or enoxaparin
|
|
12
|
Prophylactic anticoagulation and clopidogrel
|
Yes or no at inpatient admission
|
|
13
|
Therapeutical anticoagulation
|
Therapeutical anticoagulation with heparin or enoxaparin at inpatient admission
|
|
14
|
Therapeutical anticoagulation and clopidogrel
|
Therapeutical anticoagulation with heparin or enoxaparin and clopidogrel at inpatient
admission
|
|
15
|
LOS
|
Length of hospital stay
|
|
16
|
ROI
|
Recurrence of infection
|
Abbreviation: CRP, C-reactive protein.
Discussion
Our analysis shows that already at admission there are specific determinants of an
LOS longer than mean and much fewer specific determinants of ROI after healing in
patients presenting with DSWI. Modifying these determinants should have an impact
on LOS longer than mean and ROI after complete healing.
DSWI is a rare but potentially devastating complication of median sternotomy performed
in cardiac surgery. The incidence of DSWI is reported to be between 0.2 and 3%.[6] Obesity, bilateral internal mammaria artery grafts plus diabetes, prolonged operative
time, ICU treatment > 5 days, reexploration, and the need for repeated blood transfusions
in the early postoperative period are reported as predictors for DSWI.[2]
[4]
[11]
[12] Pectoralis muscle flaps are the workhorse for complex sternal wound coverage, but
complications after flap reconstruction for DSWIs remain high. In a retrospective
study including 119 cases from 2007 to 2008, end-stage renal disease and vertical
rectus abdominis myocutaneous reconstruction were associated with the complicated
postoperative course in these patients.[5]
In addition to the literature, our analysis examines for the first time determinants
of LOS longer than mean and ROI after complete healing among patients send to the
hospital for DSWI. In fee-for-service countries like Germany, reimbursement becomes
more and more important for hospitals. An LOS longer than mean and an early ROI after
complete healing during in-hospital stay are important factors that reduce profit
and thus threaten the existence of the hospital. The question is whether these determinants
can effectively be addressed before admission.
Pech et al analyzed the treatment of 130 patients treated by latissimus flap to cover
sternal wounds between 2009 and 2015 retrospectively.[7] The reoperation rate because of wound healing problems was 21.5% and bleeding complications
leading to reoperation occurred in 10.8% of all patients. In this setting, high dose
therapy with danaparoid/fondaparinux was a significant risk factor for bleeding complications
needing reoperation. The LOS longer than the mean of patients in our study taking
clopidogrel and therapeutically dosed heparin was also most likely attributable to
bleeding complications. In particular, stepwise subtotal resection of the sternum
may provoke postoperative bleeding requiring revision, thus increasing the number
of surgical procedures until final defect coverage and prolonging the LOS. Prolonged
LOS due to renal failure is most likely due to the disease itself. Indeed, multiple
studies have shown that the presence of renal insufficiency has no influence on the
development of mediastinitis and sternal osteomyelitis.[11]
[13] In particular, number of days for hemodialysis and complications due to renal insufficiency,
such as electrolyte imbalance or the development of peripheral edema and interstitial
pulmonary edema, can significantly prolong the duration of hospitalization.[14] Women make up the majority of the collective in our study with 51%. The composition
of our collective is thus different from that in other large studies, in which the
proportion of women is significantly underrepresented.[15]
[16] Previously, female sex had been described only as an independent risk factor for
increased lethality in the setting of cardiac surgery.[16] Our data now show that female sex is also a risk factor for prolonged hospitalization
in the setting of treatment for severe sternal osteomyelitis with four or more operations
until defect coverage.
However, contrary to what has been demonstrated in several other studies, our data
do not show an increased ROI requiring revision after defect coverage in the female
sex and thus coincides, for example, with the study results of Spindler et al.[17] We were unable to demonstrate the consideration that lateral traction forces of
large mammaries lead to wound healing problems requiring revision.[18]
[19]
In our study, obesity and immunosuppressant use played a statistically relevant role
in the ROI requiring revision after defect coverage by pectoralis major flap surgery. Just as
Kozlow et al[20] and Pech et al[7] demonstrated in their study, we also assume that the increased incidence of ROI
after defect coverage can be explained by an increased traction force on the flap
plastic due to the massive overweight. Nevertheless, not the obesity but the use of
immunosuppressants is the main determinant for ROI in our study. In the group of patients
considered for ROI in our collective only six (12.2%) took immunosuppressants: every
6 with chronic obstructive pulmonary disease. Elevated glucocorticoid levels, whether
endogenous or exogenous, affect wound healing.[18] Systematic glucocorticoid therapy results in increased granulation tissue formation
and decreased wound contraction.[21] Various animal studies show that wound healing is inhibited by glucocorticoids in
a dose-dependent manner, particularly in the perioperative and early phases of wound
healing.[22] Several clinical studies can also demonstrate this effect,[23] just like our study now.
The final question is whether the described determinants can be addressed before admission
to reduce the rate of patients with LOS longer than mean and ROI. From the three determinants
female sex, clopidogrel and therapeutic anticoagulation and renal insufficiency, only
clopidogrel and therapeutic anticoagulation could actively be changed, depending on
the timing of treatment. Only clopidogrel is mentioned in our study as we already
change prasugrel and ticagrelor to clopidogrel before hospital admission. With the
changing recommendations in the guidelines in the last years[24] in some patients on therapeutic anticoagulation, we ask the cardiologist to stop
clopidogrel earlier today. The same comes true for immunosuppressants. These are only
8% of the admitted patients and already today we discuss the necessity of this therapy
in each patient.
Overall, with the knowledge of risk factors that prolong LOS longer than mean, it
would be additionally desirable to adapt the DRG system in Germany to the multimorbid
patients with mediastinitis. However, recent years have shown that the refinancing
of critically ill patients with mediastinitis is becoming increasingly difficult and
that the DRG system is far from adapting.
Limitation
Although the analysis is based on detailed data regarding patients' characteristics,
comorbidities, and treatment, it is a retrospective and monocentric study. The endpoint
LOS above mean is very specific for the German DRG system and might not be relevant
in other health systems. In addition, the study did not take into account whether
the patients were undergoing complex intensive care or were being treated in the normal
ward. The risk factor for DWSI reported in the literature is bilateral internal mammaria
artery grafts. We did not consider initial surgical techniques which could also have
an impact on musculocutaneous flap healing.
In conclusion, our study is the first to examine risk factors and complications that
prolong recumbency in the setting of sternal osteomyelitis. These data can be used
to further determine the risk of complications preoperatively based on gender, pre-existing
conditions, and medication use. They help to explain prolonged and severe courses
of disease and can also be used for a differentiated assessment of courses of disease.
Nonetheless, this study encourages consideration of the risk factors for prolonged
hospitalization in the treatment of sternal osteomyelitis. Addressing risk factors
could reduce LOS and lower costs.
